Anteris Technologies Global (AVR) Stock Analysis & AI Equity Report

Medical - Devices USD Explore free reports

Anteris Technologies Global (AVR) overview

Anteris Technologies Global (AVR) stock analysis and AI equity research. For financial year 2025, Valuatum's model shows revenue of USD 1.9m and operating profit of USD -93.9m; the year-end share price was 4.99 USD and market capitalisation was USD 207m. Anteris Technologies Global is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Anteris Technologies Global's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

Book valueUSD -0.1mFY 2025
Share price4.99 USDFY 2025 year end
RevenueUSD 1.9mFY 2025
Operating profitUSD -93.9mFY 2025
Net earningsUSD -94.1mFY 2025
Market capitalisationUSD 207mFY 2025 year end

About Anteris Technologies Global

Anteris Technologies Global develops structural heart products, including the DurAVR transcatheter heart valve system for aortic stenosis. The system combines a single-piece valve made with ADAPT tissue technology and a balloon-expandable delivery system. The company is conducting clinical studies of DurAVR and developing it for transcatheter aortic valve replacement procedures. ADAPT tissue technology is also used in other cardiac and congenital heart applications.

Generate the Anteris Technologies Global report

Anteris Technologies Global is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.

Generate fresh report — €50.00 Delivered by email, usually within an hour

Sources & methodology

Financial figures are sourced from Valuatum's financial model for Anteris Technologies Global and represent financial year 2025. See the methodology for the full Valuatum AI equity research framework.

Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.

Analyst reports on Anteris Technologies Global

Each report here is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by a score out of five: what other analysts felt the work added over the engine's default report.